Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-15-005379
Filing Date
2015-08-18
Accepted
2015-08-18 17:21:54
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gluc_10q.htm 10-Q 253985
2 CERTIFICATION gluc_ex311.htm EX-31.1 7993
3 CERTIFICATION gluc_ex321.htm EX-32.1 4028
  Complete submission text file 0001477932-15-005379.txt   1259748

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT gluc-20150630.xml EX-101.INS 135977
5 XBRL TAXONOMY EXTENSION SCHEMA gluc-20150630.xsd EX-101.SCH 24761
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gluc-20150630_cal.xml EX-101.CAL 25496
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gluc-20150630_def.xml EX-101.DEF 15808
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gluc-20150630_lab.xml EX-101.LAB 151529
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gluc-20150630_pre.xml EX-101.PRE 74602
Mailing Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712
Business Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712 (888) 987-6315
Glucose Health, Inc. (Filer) CIK: 0001420108 (see all company filings)

EIN.: 980557171 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55439 | Film No.: 151062219
SIC: 2833 Medicinal Chemicals & Botanical Products